Philippe Khau-Van-Kien

Dr. Philippe Khau-Van-Kien

1. UF de Génétique Médicale et Cytogénétique, Centre Hospitalier Régional Universitaire de Nîmes, Nîmes, France
+1

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
AGAurore Garde
Aurore Garde
JCJenny Cornaton
Jenny Cornaton
ASArthur Sorlin
Arthur Sorlin
SMSébastien Moutton
Sébastien Moutton
CNClaire Nicolas
Claire Nicolas
LFLaurence Faivre
Laurence Faivre

21 October 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
BCBertrand CHESNEAU
Bertrand CHESNEAU
APAurélie Plancke
Aurélie Plancke
GRGuillaume Rolland
Guillaume Rolland
BMBertrand Marcheix
Bertrand Marcheix
YDYves Dulac
Yves Dulac
PKPhilippe Khau-Van-Kien
Philippe Khau-Van-Kien
Background: Pathogenic variants in MYH11 are associated with either heritable thoracic aortic aneurysm and dissection (HTAAD), patent ductus arteriosus (PDA) syndrome, or megacystis‐microcolon‐intestinal hypoperistalsis syndrome (MMIHS).Methods and Results: We report a family referred for molecular diagnosis with HTAAD/PDA phenotype in which we found a variant at a non‐conserved position of the 5’ donor splice site of intron 32 of MYH11 potentially altering splicing (NM_002474.3:c.4578+3A>C). Although its cosegregation with disease was observed, it remained of unknown significance. Later, aortic surgery in the proband gave us the opportunity to perform a transcript analysis. This showed a skipping of the exon 32, an RNA defect previously reported to be translated to an in‐frame loss of 71 amino acids and a dominant‐negative effect in the smooth muscle myosin rod. This RNA defect is also reported in 3 other HTAAD/PDA pedigrees.Conclusion: This report confirms that among rare variants in MYH11, skipping of exon 32 is recurrent. This finding is of particular interest to establish complex genotype–phenotype correlations where some alleles are associated with autosomal dominant HTAAD/PDA, while others result in recessive or dominant visceral myopathies.

14 August 2023 in Clinical Genetics
Verified
Journal Article
Closed access
LFLaurence Faivre
Laurence Faivre
JCJean‐Charles Crépin
Jean‐Charles Crépin
MRManon Réda
Manon Réda
SNSophie Nambot
Sophie Nambot
VCVirginie Carmignac
Virginie Carmignac
PVPierre Vabres
Pierre Vabres

1 July 2010 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
LFLaurence Faivre
Laurence Faivre
PKPhilippe Khau-Van-Kien
Philippe Khau-Van-Kien
PCPatrick Callier
Patrick Callier
NRNathalie Ruiz-Pallares
Nathalie Ruiz-Pallares
CBCorinne Baudoin
Corinne Baudoin
FMFrancine Mugneret
Francine Mugneret

7 January 2021 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
BCBertrand CHESNEAU
Bertrand CHESNEAU
APAurélie Plancke
Aurélie Plancke
GRGuillaume Rolland
Guillaume Rolland
NCNicolas Chassaing
Nicolas Chassaing
CCChristine Coubes
Christine Coubes
PKPhilippe Khau-Van-Kien
Philippe Khau-Van-Kien
Marfan syndrome (MFS) is a heritable connective tissue disorder (HCTD) caused by pathogenic variants in FBN1 that frequently occur de novo. Although individuals with somatogonadal mosaicisms have been reported with respect to MFS and other HCTD, the overall frequency of parental mosaicism in this pathology is unknown. In an attempt to estimate this frequency, we reviewed all the 333 patients with a disease-causing variant in FBN1. We then used direct sequencing, combined with High Resolution Melting Analysis, to detect mosaicism in their parents, complemented by NGS when a mosaicism was objectivized. We found that (1) the number of apparently de novo events is much higher than the classically admitted number (around 50% of patients and not 25% as expected for FBN1) and (2) around 5% of the FBN1 disease-causing variants were not actually de novo as anticipated, but inherited in a context of somatogonadal mosaicisms revealed in parents from three families. High Resolution Melting Analysis and NGS were more efficient at detecting and evaluating the level of mosaicism compared to direct Sanger sequencing. We also investigated individuals with a causal variant in another gene identified through our “aortic diseases genes” NGS panel and report, for the first time, on an individual with a somatogonadal mosaicism in COL5A1. Our study shows that parental mosaicism is not that rare in Marfan syndrome and should be investigated with appropriate methods given its implications in patient’s management.

21 January 2026 in Clinical Genetics
Verified
Journal Article
Open access
OZOmar Zgheib
Omar Zgheib
TRThomas Rio‐Frio
Thomas Rio‐Frio
MGMichel Guipponi
Michel Guipponi
TNThierry Nouspikel
Thierry Nouspikel
SFSiv Fokstuen
Siv Fokstuen
PKPhilippe Khau-Van-Kien
Philippe Khau-Van-Kien
Distal arthrogryposis constitutes a highly heterogeneous group of disorders with a critical need for clear classification. Phenotypes have traditionally been characterized using the classification system proposed by Bamshad or Hall for distal arthrogryposis. Recessive MYH3 inheritance has been described in contractures, pterygia and spondylocarpotarsal fusion syndrome, and, more recently, in distal arthrogryposis without skeletal fusion. We hereby report a nuclear family affected by distal arthrogryposis with biallelic MYH3 ‐related disorder, identifying two novel variants, which in the heterozygous state yield a subclinical phenotype. Beyond refining the molecular diagnosis and guiding genetic counseling, our study emphasizes that the classification of MYH3 ‐related disorders and their inheritance modes is still evolving, underscoring the need to integrate knowledge gained from careful analyses.